MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BKYI had -$235,492 decrease in cash & cash equivalents over the period. -$1,124,089 in free cash flow.

Cash Flow Overview

Change in Cash
-$235,492
Free Cash flow
-$1,124,089
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from note payable
    • Due from factor
    • Amortization of note payable
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Deferred revenue
    • Accounts payable
    • Others

Cash Flow
2025-09-30
2025-06-30
Operating leases right-of-use assets
-12,543
Net loss
-964,849 -1,903,941
Depreciation
21,266 43,748
Amortization of intangible assets
56,329 154,738
Amortization of capitalized contract costs
42,448 91,766
Amortization of note payable
60,000 120,000
Interest payable on note
12,680 60,175
Reserve for inventory
0 -
Operating leases right-of-use assets
18,939 -
Share and warrant-based compensation for employees and consultants
31,660 74,325
Stock based directors fees
0 20,004
Bad debts
0 15,000
Accounts receivable
-24,030 15,305
Allowance for credit losses
0 -250,000
Due from factor
-154,769 80,599
Capitalized contract costs
11,200 49,465
Inventory
75,638 -59,769
Resalable software license rights
0 -
Prepaid expenses and other
49,330 24,397
Accounts payable
-233,331 71,322
Accrued liabilities
43,488 -107,843
Deferred revenue
-235,350 619
Operating lease liabilities
-6,132 -7,783
Net cash used in operating activities
-1,122,764 -1,715,324
Capital expenditures
1,325 6,048
Net cash used in investing activities
-1,325 -6,048
Proceeds for exercise of warrants
0 3,813,057
Offering costs
0 248,783
Proceeds from note payable
1,000,000 0
Receipt of cash from employee stock purchase plan
0 876
Repayment of government loan
-37,492 -71,645
Net cash provided by financing activities
962,508 3,493,505
Effect of exchange rate changes
-73,911 65,608
Net increase in cash and cash equivalents
-235,492 1,837,741
Cash and cash equivalents at beginning of period
437,604 -
Cash and cash equivalents at end of period
2,039,853 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from notepayable$1,000,000 Net cash provided byfinancing activities$962,508 Canceled cashflow$37,492 Net increase in cashand cash...-$235,492 Canceled cashflow$962,508 Due from factor-$154,769 Amortization of note payable$60,000 Amortization of intangibleassets$56,329 Accrued liabilities$43,488 Amortization of capitalizedcontract costs$42,448 Share andwarrant-based compensation...$31,660 Accounts receivable-$24,030 Depreciation$21,266 Operating leasesright-of-use assets$18,939 Interest payable on note$12,680 Repayment of governmentloan-$37,492 Net cash used inoperating activities-$1,122,764 Canceled cashflow$465,609 Effect of exchange ratechanges-$73,911 Net cash used ininvesting activities-$1,325 Net loss-$964,849 Deferred revenue-$235,350 Accounts payable-$233,331 Inventory$75,638 Prepaid expenses andother$49,330 Capitalized contract costs$11,200 Operating leaseliabilities-$6,132 Capital expenditures$1,325

BIO KEY INTERNATIONAL INC (BKYI)

BIO KEY INTERNATIONAL INC (BKYI)